loading
Adial Pharmaceuticals Inc stock is traded at $1.01, with a volume of 25,968. It is down -0.98% in the last 24 hours and down -5.61% over the past month. Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
See More
Previous Close:
$1.02
Open:
$1.01
24h Volume:
25,968
Relative Volume:
0.18
Market Cap:
$6.47M
Revenue:
-
Net Income/Loss:
$-6.07M
P/E Ratio:
-0.134
EPS:
-7.54
Net Cash Flow:
$-7.34M
1W Performance:
-11.40%
1M Performance:
-5.61%
6M Performance:
-27.86%
1Y Performance:
-53.67%
1-Day Range:
Value
$0.9997
$1.02
1-Week Range:
Value
$0.9924
$1.15
52-Week Range:
Value
$0.765
$4.1699

Adial Pharmaceuticals Inc Stock (ADIL) Company Profile

Name
Name
Adial Pharmaceuticals Inc
Name
Phone
434-422-9800
Name
Address
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
Name
Employee
7
Name
Twitter
@AdialPharma
Name
Next Earnings Date
2024-12-12
Name
Latest SEC Filings
Name
ADIL's Discussions on Twitter

Compare ADIL with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
ADIL 1.01 6.47M 0 -6.07M -7.34M -7.54
VRTX 448.10 115.74B 10.63B -479.80M -1.35B 13.33
REGN 746.52 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 590.04 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.65 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.86 24.49B 3.30B -501.07M 1.03B 11.54

Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-30-18 Initiated Maxim Group Buy
Oct-11-18 Initiated Dawson James Buy

Adial Pharmaceuticals Inc Stock (ADIL) Latest News

pulisher
Nov 16, 2024

Adial Pharmaceuticals (NASDAQ:ADIL) Coverage Initiated at Rodman & Renshaw - Defense World

Nov 16, 2024
pulisher
Nov 16, 2024

RODMAN&RENSHAW Upgrades Adial Pharmaceuticals (NASDAQ:ADIL) to “Strong-Buy” - Defense World

Nov 16, 2024
pulisher
Nov 15, 2024

Rodman & Renshaw sets stock target, buy rating on Adial Pharma, cites potential - Investing.com India

Nov 15, 2024
pulisher
Nov 14, 2024

ARMISTICE CAPITAL, LLC Acquires New Stake in Adial Pharmaceutica - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

U.S. STOCKS Oklo, Adial Pharma, Sonos - XM

Nov 14, 2024
pulisher
Nov 14, 2024

EXCLUSIVE: Adial Pharmaceuticals Reveals Topline Results From Pharmacokinetics Study Of AD04 For Alcohol Use Disorder - AOL

Nov 14, 2024
pulisher
Nov 14, 2024

Adial Pharmaceuticals completes key study for FDA meeting - Investing.com

Nov 14, 2024
pulisher
Nov 14, 2024

Adial Pharmaceuticals Announces Positive Topline Results - GlobeNewswire

Nov 14, 2024
pulisher
Nov 14, 2024

Adial Pharma's AD04 Drug Hits Key Milestones in Alcohol Use Disorder Treatment Study | ADIL Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 14, 2024

This Turning Point Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Nov 14, 2024
pulisher
Nov 14, 2024

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Short Interest Update - Defense World

Nov 14, 2024
pulisher
Nov 14, 2024

Adial Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Nov 14, 2024
pulisher
Nov 13, 2024

Adial Pharma Reports Mixed Q3: AUD Drug Study Advances Despite Widening Losses | ADIL Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 07, 2024

Adial Pharmaceuticals Appoints Vinay Shah as CFO - Defense World

Nov 07, 2024
pulisher
Nov 06, 2024

Adial Pharmaceuticals names new CFO amid strategic growth By Investing.com - Investing.com Australia

Nov 06, 2024
pulisher
Nov 05, 2024

Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer - GlobeNewswire

Nov 05, 2024
pulisher
Nov 05, 2024

Adial Pharmaceuticals names new CFO amid strategic growth - Investing.com

Nov 05, 2024
pulisher
Nov 05, 2024

Adial Pharma Taps Veteran CFO with $150M+ Fundraising Track Record | Key Executive Move | ADIL Stock News - StockTitan

Nov 05, 2024
pulisher
Oct 23, 2024

Adial Pharmaceuticals to Present at the 2024 ThinkEquity Conference - The Manila Times

Oct 23, 2024
pulisher
Oct 17, 2024

EXCLUSIVE: Adial Pharmaceuticals Secures Additional US Patent Expanding Intellectual Property Protection Around Its Alcohol Use Disorder Candidate - AOL

Oct 17, 2024
pulisher
Oct 17, 2024

Adial Pharmaceuticals patent expands for alcohol disorder drug - Investing.com

Oct 17, 2024
pulisher
Oct 17, 2024

Adial Pharmaceuticals patent expands for alcohol disorder drug By Investing.com - Investing.com Canada

Oct 17, 2024
pulisher
Oct 17, 2024

Adial Pharmaceuticals Receives Notice of Allowance for U.S. - GlobeNewswire

Oct 17, 2024
pulisher
Oct 15, 2024

Adial Pharmaceuticals Commends the National Institute on Alcohol Abuse and Alcoholism's New Definition of Recovery - GlobeNewswire

Oct 15, 2024
pulisher
Sep 26, 2024

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Short Interest Down 46.2% in September - Defense World

Sep 26, 2024
pulisher
Sep 19, 2024

Analyzing ADI’s price-to-book ratio for the last quarter - US Post News

Sep 19, 2024
pulisher
Sep 19, 2024

Adial Pharmaceuticals completes key study stage for AUD drug - Investing.com

Sep 19, 2024
pulisher
Sep 19, 2024

Adial Pharmaceuticals Announces Database Lock in - GlobeNewswire

Sep 19, 2024
pulisher
Sep 19, 2024

Adial Pharmaceuticals Announces Database Lock in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder - StockTitan

Sep 19, 2024
pulisher
Sep 19, 2024

Analog Devices Inc. (ADI) Stock: A Year of Declines and Increases - The InvestChronicle

Sep 19, 2024
pulisher
Sep 19, 2024

MQS Management LLC Increases Stock Position in Analog Devices, Inc. (NASDAQ:ADI) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Addex Therapeutics Reports Profitable H1 2024 - TipRanks

Sep 19, 2024
pulisher
Sep 19, 2024

Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit - GlobeNewswire

Sep 19, 2024
pulisher
Sep 18, 2024

Recent Insider Activity Could Benefit Adaptimmune Therapeutics Plc ADR (ADAP) - Knox Daily

Sep 18, 2024
pulisher
Sep 18, 2024

ADMA Biologics stock soars to all-time high of $19.36 - Investing.com

Sep 18, 2024
pulisher
Sep 18, 2024

ADMA Biologics Stock Soars 76.2% in 3 Months: Right Time to Invest? - Yahoo Finance

Sep 18, 2024
pulisher
Sep 18, 2024

Adial Pharmaceuticals (NASDAQ:ADIL) versus Galapagos (NASDAQ:GLPG) Head-To-Head Comparison - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Analog Devices (NASDAQ:ADI) shareholders notch a 17% CAGR over 5 years, yet earnings have been shrinking - Yahoo Finance

Sep 18, 2024
pulisher
Sep 18, 2024

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement - Eagle-Tribune

Sep 18, 2024
pulisher
Sep 18, 2024

ADM Investor Services Singapore Becomes Abaxx Exchange's Third Clearing and Trading Member - GlobeNewswire

Sep 18, 2024
pulisher
Sep 18, 2024

Raymond James lifts Adma Biologics Inc [ADMA] price estimate. Who else is bullish? - The DBT News

Sep 18, 2024
pulisher
Sep 17, 2024

Keeping an Eye on Adma Biologics Inc (ADMA) After Insider Trading Activity - Knox Daily

Sep 17, 2024
pulisher
Sep 17, 2024

Adma Biologics Inc (NASDAQ:ADMA) stock crossing the finish line today - US Post News

Sep 17, 2024
pulisher
Sep 17, 2024

Analytical Overview: Adma Biologics Inc (ADMA)’s Ratios Tell a Financial Story - The Dwinnex

Sep 17, 2024
pulisher
Sep 17, 2024

A new trading data show Adaptimmune Therapeutics Plc ADR (ADAP) is showing positive returns. - SETE News

Sep 17, 2024
pulisher
Sep 17, 2024

ADIA Nutrition Stakes Claim in $6.7B Industry with Strategic Trademark Expansion - Marketscreener.com

Sep 17, 2024
pulisher
Sep 17, 2024

ADMA Biologics set to join S&P SmallCap 600 index By Investing.com - Investing.com Canada

Sep 17, 2024
pulisher
Sep 17, 2024

Take off with Applied Dna Sciences Inc (APDN): Get ready for trading - SETE News

Sep 17, 2024
pulisher
Sep 17, 2024

ADMA Biologics Set to Join S&P SmallCap 600 Index - Yahoo Finance

Sep 17, 2024
pulisher
Sep 16, 2024

Adma Biologics Inc (ADMA) Stock: The Story of a 52-Week Stock Range - The InvestChronicle

Sep 16, 2024
pulisher
Sep 16, 2024

Adma Biologics Inc (ADMA) Performance and Fundamentals Dashboard tells a completely different story - SETE News

Sep 16, 2024

Adial Pharmaceuticals Inc Stock (ADIL) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Cap:     |  Volume (24h):